Cover Image

Various zebrafish models of Parkinson’s disease: what gives us hope

The selection of appropriate animal models to study neurodegenerative and neurodevelopmental disorders, including Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease, schizophrenia, and epilepsy, depends on various criteria and limitations (Pienaar et al., 2010). An ideal animal...

Full description

Saved in:
Bibliographic Details
Main Authors: Soliman Wadan, Al-Hassan, Mohamed, Wael Mohamed Yousef
Format: Book Chapter
Language:Arabic
Published: Elsevier 2025
Subjects:
R Medicine (General)
Online Access:http://irep.iium.edu.my/116362/7/116362_Various%20zebrafish%20models%20of%20Parkinson%E2%80%99s%20disease.pdf
http://irep.iium.edu.my/116362/
https://shop.elsevier.com/books/translational-models-of-parkinson-s-disease-and-related-movement-disorders/mohamed/978-0-443-16128-5
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.iium.irep.116362
record_format dspace
spelling my.iium.irep.1163622024-12-04T08:33:13Z http://irep.iium.edu.my/116362/ Various zebrafish models of Parkinson’s disease: what gives us hope Soliman Wadan, Al-Hassan Mohamed, Wael Mohamed Yousef R Medicine (General) The selection of appropriate animal models to study neurodegenerative and neurodevelopmental disorders, including Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease, schizophrenia, and epilepsy, depends on various criteria and limitations (Pienaar et al., 2010). An ideal animal model of PD should demonstrate histopathological characteristics such as progressive loss of dopaminergic neurons and nondopaminergic neurons, with symptoms appearing in adulthood (Barnhill et al., 2020). These models should also mimic clinical manifestations of PD, including motor features responsive to L-DOPA therapy, like bradykinesia, rigidity, postural instability, and resting tremor (Breger & Fuzzati Armentero, 2019; Pienaar et al., 2010). Rodent and primate models have been developed to explore disease mechanisms and enhance therapeutic outcomes using neurotoxic substances or genetic manipulation. Various toxins, such as 6-hydroxydopamine (6-OHDA), rotenone, paraquat, and 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP), have been used to selectively destroy nigrostriatal DA neurons, resulting in PD-like symptoms in animals (Burns et al., 1983; McKinley et al., 2005). Rotenone models are preferred for assessing neuroprotection due to their independent mechanism of neurotoxicity from the DA uptake transporter (DAT) (Pienaar et al., 2009; Tapias et al., 2010). Though these models offer valuable insights, they do not fully replicate all human PD symptoms. Transgenic approaches involving gene manipulation, such as overexpression, knock-out, knock-in, and knock-down of PD genes, have been used to study PD (Sfar et al., 2009; Xiong et al., 2009). However, high-throughput screenings for genetic interactions or pharmacological therapies can be costly and time-consuming when using murine or nonhuman primate models (Faust et al., 2009). As alternatives, models involving zebrafish (ZF), fruit flies, nematodes, and anurans have gained attraction due to their efficiency and contribution to understanding disease mechanisms and novel therapeutic strategies (Pienaar et al., 2010). Elsevier 2025 Book Chapter PeerReviewed application/pdf ar http://irep.iium.edu.my/116362/7/116362_Various%20zebrafish%20models%20of%20Parkinson%E2%80%99s%20disease.pdf Soliman Wadan, Al-Hassan and Mohamed, Wael Mohamed Yousef (2025) Various zebrafish models of Parkinson’s disease: what gives us hope. In: Translational Models of Parkinson’s Disease and related Movement Disorders. Elsevier, London, UK, pp. 219-230. ISBN 9780443161285 https://shop.elsevier.com/books/translational-models-of-parkinson-s-disease-and-related-movement-disorders/mohamed/978-0-443-16128-5 10.1016/B978-0-443-16128-5.00013-X
institution Universiti Islam Antarabangsa Malaysia
building IIUM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider International Islamic University Malaysia
content_source IIUM Repository (IREP)
url_provider http://irep.iium.edu.my/
language Arabic
topic R Medicine (General)
spellingShingle R Medicine (General)
Soliman Wadan, Al-Hassan
Mohamed, Wael Mohamed Yousef
Various zebrafish models of Parkinson’s disease: what gives us hope
description The selection of appropriate animal models to study neurodegenerative and neurodevelopmental disorders, including Parkinson’s disease (PD), Alzheimer’s disease (AD), Huntington’s disease, schizophrenia, and epilepsy, depends on various criteria and limitations (Pienaar et al., 2010). An ideal animal model of PD should demonstrate histopathological characteristics such as progressive loss of dopaminergic neurons and nondopaminergic neurons, with symptoms appearing in adulthood (Barnhill et al., 2020). These models should also mimic clinical manifestations of PD, including motor features responsive to L-DOPA therapy, like bradykinesia, rigidity, postural instability, and resting tremor (Breger & Fuzzati Armentero, 2019; Pienaar et al., 2010). Rodent and primate models have been developed to explore disease mechanisms and enhance therapeutic outcomes using neurotoxic substances or genetic manipulation. Various toxins, such as 6-hydroxydopamine (6-OHDA), rotenone, paraquat, and 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP), have been used to selectively destroy nigrostriatal DA neurons, resulting in PD-like symptoms in animals (Burns et al., 1983; McKinley et al., 2005). Rotenone models are preferred for assessing neuroprotection due to their independent mechanism of neurotoxicity from the DA uptake transporter (DAT) (Pienaar et al., 2009; Tapias et al., 2010). Though these models offer valuable insights, they do not fully replicate all human PD symptoms. Transgenic approaches involving gene manipulation, such as overexpression, knock-out, knock-in, and knock-down of PD genes, have been used to study PD (Sfar et al., 2009; Xiong et al., 2009). However, high-throughput screenings for genetic interactions or pharmacological therapies can be costly and time-consuming when using murine or nonhuman primate models (Faust et al., 2009). As alternatives, models involving zebrafish (ZF), fruit flies, nematodes, and anurans have gained attraction due to their efficiency and contribution to understanding disease mechanisms and novel therapeutic strategies (Pienaar et al., 2010).
format Book Chapter
author Soliman Wadan, Al-Hassan
Mohamed, Wael Mohamed Yousef
author_facet Soliman Wadan, Al-Hassan
Mohamed, Wael Mohamed Yousef
author_sort Soliman Wadan, Al-Hassan
title Various zebrafish models of Parkinson’s disease: what gives us hope
title_short Various zebrafish models of Parkinson’s disease: what gives us hope
title_full Various zebrafish models of Parkinson’s disease: what gives us hope
title_fullStr Various zebrafish models of Parkinson’s disease: what gives us hope
title_full_unstemmed Various zebrafish models of Parkinson’s disease: what gives us hope
title_sort various zebrafish models of parkinson’s disease: what gives us hope
publisher Elsevier
publishDate 2025
url http://irep.iium.edu.my/116362/7/116362_Various%20zebrafish%20models%20of%20Parkinson%E2%80%99s%20disease.pdf
http://irep.iium.edu.my/116362/
https://shop.elsevier.com/books/translational-models-of-parkinson-s-disease-and-related-movement-disorders/mohamed/978-0-443-16128-5
_version_ 1817841092920344576
score 13.223943

Similar Items